In order to explore potential novel mechanisms underlying the beneficial impact of KCa3.1 silencing, we performed bulk RNA sequencing of diseased BCA from both Apoe−/− and DKO mice to identify unique transcriptomic signatures induced by KCa3.1 silencing in atherosclerosis. The gene discussed is KCNN4; the disease is atherosclerosis.